KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Goodwill & Intangibles: 2022-2025

Historic Goodwill & Intangibles for Rigel Pharmaceuticals (RIGL) over the last 3 years, with Sep 2025 value amounting to $25.3 million.

  • Rigel Pharmaceuticals' Goodwill & Intangibles fell 8.49% to $25.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.3 million, marking a year-over-year decrease of 8.49%. This contributed to the annual value of $27.1 million for FY2024, which is 95.27% up from last year.
  • As of Q3 2025, Rigel Pharmaceuticals' Goodwill & Intangibles stood at $25.3 million, which was down 2.27% from $25.9 million recorded in Q2 2025.
  • Rigel Pharmaceuticals' 5-year Goodwill & Intangibles high stood at $28.9 million for Q1 2024, and its period low was $13.9 million during Q4 2023.
  • Over the past 3 years, Rigel Pharmaceuticals' median Goodwill & Intangibles value was $25.9 million (recorded in 2025), while the average stood at $22.4 million.
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first surged by 96.60% in 2024, then fell by 8.49% in 2025.
  • Quarterly analysis of 4 years shows Rigel Pharmaceuticals' Goodwill & Intangibles stood at $14.9 million in 2022, then declined by 7.16% to $13.9 million in 2023, then surged by 95.27% to $27.1 million in 2024, then dropped by 8.49% to $25.3 million in 2025.
  • Its last three reported values are $25.3 million in Q3 2025, $25.9 million for Q2 2025, and $26.5 million during Q1 2025.